Integrated Osteoporosis Care to Reduce Denosumab-Associated Hypocalcemia for Patients with Advanced Chronic Kidney Disease and End-Stage Renal Disease

The incidence of hypocalcemia is high in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) undergoing denosumab treatment. Since 2018, we have carried out a “multidisciplinary integrated care program for osteoporosis among patients with CKD and ESRD” in our hospital. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chia-Tien, Deng, Ya-Lian, Chung, Mu-Chi, Tsai, Shang-Feng, Lin, Shih-Yi, Chen, Cheng-Hsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914883/
https://www.ncbi.nlm.nih.gov/pubmed/36766888
http://dx.doi.org/10.3390/healthcare11030313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914883/
https://www.ncbi.nlm.nih.gov/pubmed/36766888
http://dx.doi.org/10.3390/healthcare11030313

Ejemplares similares